Viewing Study NCT01840696



Ignite Creation Date: 2024-05-06 @ 1:33 AM
Last Modification Date: 2024-10-26 @ 11:06 AM
Study NCT ID: NCT01840696
Status: WITHDRAWN
Last Update Posted: 2014-06-02
First Post: 2013-04-16

Brief Title: Phase Analysis and Obstructive CAD on Rubidium PET
Sponsor: Emory University
Organization: Emory University

Study Overview

Official Title: Regional and Global Left Ventricular Mechanical Dyssynchrony in the Diagnosis of Obstructive Coronary Artery Disease on Rest and Regadenoson Stress Rubidium Myocardial Perfusion PET
Status: WITHDRAWN
Status Verified Date: 2014-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: PI leaving facility
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Rubidium myocardial perfusion PET is an imaging test used to diagnose patients with abnormal blood flow to the heart secondary to narrowing of the heart vessels

Phase analysis is a computer method that is applied after the PET test is done It is used to determine when a region of the heart contracts relative to other heart regions in the heart beating cycle Initial data suggest that regions of the heart with abnormal blood flow change the pattern of contraction from rest to stress conditions That is regions of the heart with abnormal blood supply become dyssynchronous when compared to the normal regions of the heart

This study will investigate whether phase analysis may aid the visual interpretation of rubidium myocardial perfusion PET studies by determining the areas of the heart that are not beating in synchrony with the normal heart regions This information will be used as a proxy for poor blood supply The gold standard will be coronary angiography by which the percent narrowing of the heart vessels is assessed
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
REGA12I11 OTHER Other None